Proportion of isolates with resistance to azithromycin reported to in Latvia
Latvia: Proportion of isolates with resistance to azithromycin reported to was 14.3 in 2019. ◆ Volatile
Proportion of isolates with resistance to azithromycin reported to in Latvia, 2009–2019
Source: World Health Organization, Global Health Observatory.
Analysis
In 2019, proportion of isolates with resistance to azithromycin reported to in Latvia stood at 14.3.
The figure is up 0.1% over five years.
Over the whole period, proportion of isolates with resistance to azithromycin reported to in Latvia peaked at 15.79 in 2013 and was at its lowest, 0, in 2009.
Latvia ranks 11th of 47 countries on this measure, in the top quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Proportion of isolates with resistance to azithromycin reported to in Latvia, year by year
| Year | Value | Change |
|---|---|---|
| 2009 | 0 | — |
| 2010 | 5 | — |
| 2011 | 3.57 | -28.6% |
| 2012 | 5.13 | +43.6% |
| 2013 | 15.79 | +207.9% |
| 2014 | 14.29 | -9.5% |
| 2015 | 0 | -100.0% |
| 2016 | 0 | — |
| 2017 | 0 | — |
| 2018 | 0 | — |
| 2019 | 14.3 | — |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0 | 0 | 0 | 1 |
| 2010s | 5.81 | 0 | 15.79 | 10 |
Countries ranked near Latvia
More health data for Latvia
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.3876 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,593 deaths per 1,000 people (2090)
- Number of infants who die before age 1 4 deaths (2100)
- Population ages 40-44, male, annual growth rate 2.09 % change on previous year (2025)
- Population ages 40-44, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 40-44, male, per capita 0.0359 units per person (2025)
- Population ages 45-49, female, annual growth rate -1.9 % change on previous year (2025)
- Population ages 45-49, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 45-49, female, per capita 0.0336 units per person (2025)
Frequently asked questions
- What is proportion of isolates with resistance to azithromycin reported to in Latvia?
- Proportion of isolates with resistance to azithromycin reported to in Latvia was 14.3 in 2019, according to World Health Organization, Global Health Observatory.
- What is the highest proportion of isolates with resistance to azithromycin reported to recorded in Latvia?
- The highest recorded value was 15.79 in 2013.
- What is the lowest proportion of isolates with resistance to azithromycin reported to recorded in Latvia?
- The lowest recorded value was 0 in 2009.
- How does Latvia rank for proportion of isolates with resistance to azithromycin reported to?
- Latvia ranks 11th out of 47 countries with data for 2019.
- Where does this Latvia data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Proportion of isolates with resistance to azithromycin reported to WHO-GASP. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 11 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).